KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $7.3 billion.

  • Johnson & Johnson's Cost of Revenue rose 488.3% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 billion, marking a year-over-year increase of 838.22%. This contributed to the annual value of $27.5 billion for FY2024, which is 345.72% up from last year.
  • Per Johnson & Johnson's latest filing, its Cost of Revenue stood at $7.3 billion for Q3 2025, which was up 488.3% from $7.6 billion recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Cost of Revenue ranged from a high of $7.9 billion in Q3 2022 and a low of $2.7 billion during Q1 2023
  • Its 5-year average for Cost of Revenue is $6.9 billion, with a median of $7.1 billion in 2021.
  • Over the last 5 years, Johnson & Johnson's Cost of Revenue had its largest YoY gain of 15215.13% in 2023, and its largest YoY loss of 1839.88% in 2023.
  • Over the past 5 years, Johnson & Johnson's Cost of Revenue (Quarter) stood at $7.3 billion in 2021, then decreased by 14.87% to $6.2 billion in 2022, then increased by 10.14% to $6.8 billion in 2023, then rose by 4.85% to $7.1 billion in 2024, then rose by 2.46% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q3 2025, $7.6 billion for Q2 2025, and $7.4 billion during Q1 2025.